BeiGene’s Tislelizumab Secures 12th Indication Approval in China for HCC First-Line Treatment
BeiGene (NASDAQ: BGNE) has announced that its programmed death-1 (PD-1) inhibitor, tislelizumab, has received approval...
BMS’ Augtyro Receives EMA Review for Advanced Lung Cancer and Solid Tumors Treatments
The European Medicines Agency (EMA) has accepted for review a filing submitted by Bristol Myers...
Allorion Therapeutics Strikes Deal with AstraZeneca for EGFR L858R Inhibitor Development and Commercialization
Allorion Therapeutics, a China-based biopharmaceutical company, has announced an exclusive option and global licensing agreement...
Orient Gene Biotech to Acquire Hangzhou Laihe Biotech, Expanding POCT and AI in Healthcare
Zhejiang Orient Gene Biotech Co., Ltd, a leading biotech company in China, is poised to...
Shanghai Teogen Life Technology and China National Medical Device Form Strategic Partnership
Shanghai Teogen Life Technology Co., Ltd, a Chinese-based company, has announced a strategic partnership with...
Shanghai Pharmaceuticals and Sanofi Broaden Collaboration to Include Nationwide Disease Management
Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) , a leading pharmaceutical company based in China,...
Servier Faces $475 Million Penalty Over Banned Antidiabetic Drug Mediator in France
French pharmaceutical company Servier has been ordered by a French court to pay €430.6 million...
J&J Shareholders Cleared to Sue Over Hidden Asbestos Risks in Talc Products
A US federal court has granted permission for certain Johnson & Johnson (J&J; NYSE: JNJ)...
China’s CDE Releases Guidelines for CGT Clinical Trials Communication
The Center for Drug Evaluation (CDE) in China has released the “Technical Guiding Principles for...
China’s NHC Unveils Plan to Conserve Drug Resources and Reduce Waste
The National Health Commission (NHC) of China, in collaboration with four other bureaus, has released...
China’s NHC Unveils Guidelines to Fortify County-Level Medical Communities
The National Health Commission (NHC) of China, in conjunction with nine other ministries, has issued...
Roche to Expand Diagnostics Portfolio with Acquisition of LumiraDx Technology
Pharmaceutical giant Roche (SWX: ROG), based in Switzerland, has announced an agreement to acquire innovative...
Huadong Medicine Ends Collaboration on vTv’s TTP273 for Diabetes Treatment
US-based vTv Therapeutics LLC has received a cancellation notice from China’s Huadong Medicine Co., Ltd.,...
Roche Secures Diagnostics Deal with LumiraDx for $295M
Switzerland’s pharmaceutical giant Roche (SWX: ROG) has sealed a deal to acquire innovative diagnostics technology...
Huadong Medicine Cancels Collaboration with vTv Therapeutics on TTP273 for Type 2 Diabetes Drug
vTv Therapeutics LLC, a US-based pharmaceutical company, has announced receiving a cancellation notification from China-based...
Jiangsu Recbio’s REC610 Shingles Vaccine Shows Positive Results in First-In-Human Study
Jiangsu Recbio Technology Co., Ltd (HKG: 2179), a Chinese biotechnology company, has announced positive results...
Innovent Biologics Initiates Phase III Trial for Mazdutide in Obesity Treatment
Innovent Biologics Inc., a biopharmaceutical company based in China (HKG: 1801), has announced the first...
Hainan Poly Pharm’s Novel Nanomedicine PLAT001 Gets US FDA Approval for Clinical Trials
Hainan Poly Pharm Co., Ltd (SHE: 300630), a Chinese pharmaceutical company, has announced that it...
CareRay Digital Medical Technology to Acquire 30% Stake in UK’s ISDI for USD 15.2 Million
CareRay Digital Medical Technology Co., Ltd, a company based in Suzhou (SHA: 688607), has announced...
Jiangsu Hengrui’s SHR-A2009 Earns Fast-Track Status for Metastatic NSCLC Treatment
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced that its in-house developed antibody-drug conjugate...